INNOPHARMAX INC.

9F, No. 22, Lane 478, Rueiguang St., Taipei City, Taipei, Taiwan

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

40.0%

Early Phase 1

20.0%

Phase 2

20.0%

Phase 3

20.0%

Trial Status Distribution

Completed

60.0%

Recruiting

40.0%

Clinical Trials

Trials sponsored by this organization (5)

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Phase 3

Recruiting

interventional

Jun 2026240 participants

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

Phase 2

Recruiting

interventional

Mar 2022180 participants

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Phase 1

Completed

interventional

Aug 201819 participants

Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas

Phase 1

Completed

interventional

Apr 201337 participants

An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

Early Phase 1

Completed

interventional

Aug 201211 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations